These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8413052

  • 1. [When must, when should, when can ACE inhibitors be administered in heart failure?].
    Jahrmärker H.
    Med Klin (Munich); 1993 Aug 15; 88(8):496-502. PubMed ID: 8413052
    [No Abstract] [Full Text] [Related]

  • 2. [ACE inhibitors in hypertension and heart failure].
    Riegger AJ.
    Internist (Berl); 1992 Oct 15; 33(10):639-44. PubMed ID: 1428682
    [No Abstract] [Full Text] [Related]

  • 3. [Angiotensin-converting enzyme inhibition: a pathophysiologically based concept for the therapy of hypertension and heart failure].
    Stumpe KO, Overlack A, Kolloch R.
    Dtsch Med Wochenschr; 1984 Aug 24; 109(34):1295-9. PubMed ID: 6088205
    [No Abstract] [Full Text] [Related]

  • 4. [Angiotensin converting enzyme inhibitors in arterial hypertension and cardiac failure. The question of the dose].
    González-Juanatey JR.
    Med Clin (Barc); 2000 Aug 24; 114 Suppl 2():24-7. PubMed ID: 10916802
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [ACE inhibitors].
    Schrader J, Gonska BD, Dominiak P.
    Internist (Berl); 1992 May 24; 33(5):356-60. PubMed ID: 1612868
    [No Abstract] [Full Text] [Related]

  • 7. Effects of atenolol as add-on therapy to fosinopril in heart failure.
    Pacher R, Hülsmann M, Berger R, Koller-Strametz J, Kos T, Frey B, Dukat A, Stanek B.
    Wien Klin Wochenschr; 1997 Apr 11; 109(7):232-8. PubMed ID: 9141231
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Angiotensin converting enzyme inhibitors. Pharmacological and physiological background for cardiovascular treatment.
    Jerie P.
    Cor Vasa; 1992 Apr 11; 34(1):31-66. PubMed ID: 1288942
    [No Abstract] [Full Text] [Related]

  • 10. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint].
    Klein W, Eber B, Gasser R, Stoschitzky K, Schumacher M, Fruhwald FM, Zweiker R.
    Wien Med Wochenschr; 1996 Apr 11; 146(11):221-4. PubMed ID: 8928518
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Finely adjusted differential therapy succeeds this way! References for dose adjustments in heart failure (interview by Dr. Dirk Einecke)].
    Erdmann E.
    MMW Fortschr Med; 2005 Sep 29; 147(39):11. PubMed ID: 16245770
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 29; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.